LyFE - Lymphoma Forum of Excellence
«What's new in lymphoid neoplasias?»

January 24-26 2025

LyFE Course

January 24-26 2025

LyFE Course

2025/01/24 09:00:00

The LyFE Course, held annually in Bellinzona, Switzerland, is a specialized program focused on lymphoid neoplasias, including myelomas. The course aims to provide participants with comprehensive and up-to-date knowledge in this complex medical field. Designed by lymphoma specialists, it offers an in-depth educational experience for professionals seeking to advance their understanding of these diseases. Since 2004, the event is organized by the Foundation for the Institute of Oncology Research (IOR).

EVENT DETAILS

  • DATE

    January 24-26, 2025

  • VENUE

    Auditorium of San Giovanni Hospital, Bellinzona, Switzerland.

  • REGISTRATION

    Registrations will open on September 1


    Please note that accommodation (3 nights at Hotel Internazionale), coffee breaks & lunches are covered by the tuition fee.

  • REGISTRATION FEE

  • EACCME ACCREDITATION

Clinical case discussions


A particular feature of the LyFE course is that each participant has the possibility to present a clinical case, which is consequently discussed by a panel of experts.

The limited number of attendees and the familiar environment contribute to create a constructive interaction between the faculty and the participants, which allows ample discussions and exchange of experience and expertise.

Course objectives and learning outcomes

  • Gain insights from leading experts in the field on the latest advancements in both the pathobiology and clinical management of various lymphoma subtypes.

  • Stay updated with new research findings and treatment modalities that are shaping the future of lymphoma care.

  • Engage in discussions centered on real cases.

  • Address diagnostic and clinical challenges in managing lymphoma patients through a problem-based learning approach.

  • Develop practical solutions and strategies for overcoming these difficulties, enhancing diagnostic accuracy and treatment efficacy.

FACULTY